Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Health Network topic
No spam. Unsubscribe anytime.
SF Health Network leaders point to integration gains, Laguna Honda recertification and cost savings
Summary
Network leadership told the Health Commission about new central functions, a recertified Laguna Honda, EPIC implementation, a 75% drop in nursing registry use since March and revenue generated through CalAIM/QIP programs; commissioners asked for follow-up on integration and fiscal impacts.
San Francisco Health Network leaders presented a wide-ranging update to the Health Commission on Sept. 17 that highlighted organizational integration, service-line alignment, and measurable operational progress across the network’s hospitals and clinics.
Roland Pickens, CEO and director of the San Francisco Health Network, described the network’s mission to provide high-quality care across Zuckerberg San Francisco General Hospital (ZSFG), Laguna Honda Hospital, primary care clinics and other programs. Pickens noted that the network’s recent leadership investments — many repurposed from existing budgeted positions — established centralized functions for clinical quality, infection prevention, contracting strategy, and experience and workforce development.
Troy Williams, the network’s chief nursing and quality officer, described operational improvements at Laguna Honda and systemwide work on infection prevention, standardized credentialing and a centralized incident-reporting system. Williams said the network reduced nursing registry spending and usage by about 75% since March through negotiated registry rates, daily data oversight and increased hiring of permanent staff.
Network clinical leaders also described CalAIM enrollment and work to expand value-based payment initiatives. Interim network medical officer Nita Ratan Alonza said CalAIM activity generated roughly $9.4 million in revenue from January 2022 through July 2024; network staff said QIP performance in the prior cycle produced estimated payments of about $65 million for fiscal-year 2023 metrics. Pharmacy leadership reported securing a new wholesaler contract, procuring over 55,000 free naloxone doses from the state (saving roughly $1.4 million), and savings via a group purchasing organization.
Commissioners praised the network for progress but requested more detailed follow-up to show how newly repurposed leadership roles coordinate with existing division functions (particularly at ZSFG) and asked for periodic updates showing how integration generates financial and clinical benefits. Pickens said the network has begun regular cross-division coordination meetings and will return with more detailed metrics on ambulatory integration, QIP trends and cost-savings from shared-services arrangements.
Why it matters: The presentation outlines system-level changes meant to stabilize clinical operations, reduce reliance on costly registries and position the network for value-based payment streams — all central to sustaining DPH services amid budget constraints.
What’s next: Network leaders will provide future briefings with more granular ambulatory and financial metrics; commissioners requested presentation of intervention outcomes and integration results at the next scheduled update.
